THIRD ROCK VENTURES LP Insider Trading $CTMX CytomX Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for THIRD ROCK VENTURES LP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of THIRD ROCK VENTURES LP. THIRD ROCK VENTURES LP is 10% Owner in bluebird bio, Inc. ($BLUE) and 10% Owner in ZAFGEN, INC. ($ZFGN) and 10% Owner in CONSTELLATION PHARMACEUTICALS INC ($CNST) and 10% Owner in AGIOS PHARMACEUTICALS INC ($AGIO) and 10% Owner in Foundation Medicine, Inc. ($FMI) and 10% Owner in CytomX Therapeutics, Inc. ($CTMX) and 10% Owner in RHYTHM PHARMACEUTICALS, INC. ($RYTM).
THIRD ROCK VENTURES LP in CytomX Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of THIRD ROCK VENTURES LP: 10% Owner
Holdings: 3,320,348 shares
Current Value: $38,184,002
Latest Transaction: Oct 19 2017
$CTMX Market Capitalization: $410.61M
$CTMX Previous Close: $11.50
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of THIRD ROCK VENTURES LP in CytomX Therapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AGIO, BLUE, CNST, CTMX, FMI, LRMR, RYTM
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 19 2017 | CTMX | CytomX Therapeutic ... | THIRD ROCK VENTURES LP | 10% Owner | Sell | J | 0.00 | 1,000,000 | 0 | 3,320,348 | 4.3 M to 3.3 M (-23.15 %) |
| Jul 13 2017 | CTMX | CytomX Therapeutic ... | THIRD ROCK VENTURES LP | 10% Owner | Sell | J | 0.00 | 850,000 | 0 | 4,320,348 | 5.2 M to 4.3 M (-16.44 %) |
| Mar 27 2017 | CTMX | CytomX Therapeutic ... | THIRD ROCK VENTURES LP | 10% Owner | Sell | S | 18.00 | 650,000 | 11,700,195 | 5,170,348 | 5.8 M to 5.2 M (-11.17 %) |
| Mar 27 2017 | CTMX | CytomX Therapeutic ... | THIRD ROCK VENTURES LP | 10% Owner | Sell | S | 17.00 | 1,000,000 | 17,000,200 | 5,820,348 | 6.8 M to 5.8 M (-14.66 %) |
| Mar 16 2017 | CTMX | CytomX Therapeutic ... | THIRD ROCK VENTURES LP | 10% Owner | Sell | J | 0.00 | 850,000 | 0 | 6,820,348 | 7.7 M to 6.8 M (-11.08 %) |
| Nov 09 2016 | CTMX | CytomX Therapeutic ... | THIRD ROCK VENTURES LP | 10% Owner | Sell | J | 0.00 | 1,000,000 | 0 | 7,670,348 | 8.7 M to 7.7 M (-11.53 %) |
| Oct 23 2015 | CTMX | CytomX Therapeutic ... | THIRD ROCK VENTURES LP | 10% Owner | Option Exercise | C | 0.00 | 565,037 | 0 | 0 | |
| Oct 23 2015 | CTMX | CytomX Therapeutic ... | THIRD ROCK VENTURES LP | 10% Owner | Option Exercise | C | 0.00 | 8,105,314 | 0 | 0 | |
| Oct 23 2015 | CTMX | CytomX Therapeutic ... | THIRD ROCK VENTURES LP | 10% Owner | Buy | C | 0.00 | 8,670,351 | 0 | 8,670,351 | 0 to 8.7 M |
Page: 1